Hydrogel-nanoparticle composites for optically modulated cancer therapeutic delivery

Journal of Controlled Release

Volumn 178, Issue 1, 2014, Pages 63-68

  Strong, Laura E ^a   Dahotre, Shreyas N ^a   West, Jennifer L ^a  

^a Duke University   (United States)

Author keywords

Cancer therapeutics; Hydrogel; N isopropylacrylamide; Nanoparticle; Thermally responsive

Indexed keywords

CANCER THERAPEUTICS; COLON CARCINOMA CELLS; EXTINCTION COEFFICIENTS; LOWER CRITICAL SOLUTION TEMPERATURE; N-ISOPROPYLACRYLAMIDES; PHYSICAL AND CHEMICAL PROPERTIES; PHYSIOLOGIC TEMPERATURE; THERMALLY RESPONSIVE;

ACRYLIC MONOMERS; CHEMICAL PROPERTIES; DISEASES; DNA; DRUG DELIVERY; GOLD; INFRARED DEVICES; NANOPARTICLES; NANOSHELLS; NANOSTRUCTURED MATERIALS; SILICA;

HYDROGELS;

COPOLYMER; DOUBLE STRANDED DNA; DOXORUBICIN; GOLD NANOPARTICLE; NANOCOMPOSITE; NANOSHELL; POLY(N ISOPROPYLACRYLAMIDE CO ACRYLAMIDE); UNCLASSIFIED DRUG;

ARTICLE; CANCER THERAPY; CARCINOMA CELL; CELL PROLIFERATION; CELL VIABILITY; COLON CARCINOMA; COMPOSITE MATERIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EXPOSURE; DRUG RELEASE; DRY WEIGHT; HEAT SENSITIVITY; HUMAN; HUMAN CELL; HYDROGEL; IRRADIATION; LIGHT EXPOSURE; MOLECULAR SIZE; NANOFABRICATION; NEAR INFRARED SPECTROSCOPY; PHASE TRANSITION; POLYMERIZATION; PRIORITY JOURNAL; TREATMENT RESPONSE;

CANCER THERAPEUTICS; HYDROGEL; N-ISOPROPYLACRYLAMIDE; NANOPARTICLE; THERMALLY RESPONSIVE;

ACRYLIC RESINS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DNA; DOXORUBICIN; DRUG DELIVERY SYSTEMS; GOLD; HYDROGELS; LASERS; MICE; NANOSHELLS; NEOPLASMS; OPTICAL PHENOMENA; SILICON DIOXIDE;

EID: 84893322819     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.01.014     Document Type: Article

References (41)

1. A. Kikuchi, and T. Okano Pulsatile drug release control using hydrogels Adv. Drug Deliv. Rev. 54 2002 53 77 (Pubitemid 34075314)
2. G. Brabant, K. Prank, and C. Schofl Pulsatile patterns in hormone secretion Trends Endocrinol. Metab. 3 1992 183 190
3. M.H. Smolensky, and N.A. Peppas Chronobiology, drug delivery, and chronotherapeutics Adv. Drug Deliv. Rev. 59 2007 828 851 (Pubitemid 47542291)
4. M. Eriguchi, F. Levi, T. Hisa, H. Yanagie, Y. Nonaka, and Y. Takeda Chronotherapy for cancer Biomed. Pharmacother. 57 2003 92 95
5. R. Siegel, C. DeSantis, K. Virgo, K. Stein, A. Mariotto, and T. Smith et al. Cancer treatment and survivorship statistics, 2012 CA Cancer J. Clin. 62 2012 220 241
6. F. Lévi, R. Zidani, and J.L. Misset Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer Lancet 350 1997 681 686 (Pubitemid 27371165)
7. L.E. Strong, and J.L. West Thermally responsive polymer-nanoparticle composites for biomedical applications Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 3 2011 307 317
8. M. Bikram, and J.L. West Thermo-responsive systems for controlled drug delivery Expert Opin. Drug Deliv. 5 2008 1077 1091
9. R. Yoshida, K. Sakai, T. Okano, and Y. Sakurai Modulating the phase transition temperature and thermosensitivity in N-isopropylacrylamide copolymer gels J. Biomater. Sci. Polym. Ed. 6 1995 585 598
10. S. Sershen, S. Westcott, N. Halas, and J. West Temperature-sensitive polymer-nanoshell composites for photothermally modulated drug delivery J. Biomed. Mater. Res. 51 2000 293 298 (Pubitemid 30452130)
11. 2-Au nanoshells for controlled drug delivery J. Control. Release 123 2007 219 227 (Pubitemid 350007822)
12. S. Oldenburg Nanoengineering of optical resonances Chem. Phys. Lett. 288 1998 243 247 (Pubitemid 128185622)
13. R.D. Averitt, S.L. Westcott, and N.J. Halas Linear optical properties of gold nanoshells J. Opt. Soc. Am. B 16 1999 1824 1832 (Pubitemid 129655820)
14. M.-C. Daniel, and D. Astruc Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology Chem. Rev. 104 2004 293 346
15. R.D. Averitt, S.L. Westcott, and N.J. Halas Ultrafast optical properties of gold nanoshells J. Opt. Soc. Am. B 16 1999 1814 1823 (Pubitemid 129655819)
16. R. Weissleder A clearer vision for in vivo imaging Nat. Biotechnol. 19 2001 316 317
17. L.R. Hirsch, A.M. Gobin, A.R. Lowery, F. Tam, R.A. Drezek, and N.J. Halas et al. Metal nanoshells Ann. Biomed. Eng. 34 2006 15 22
18. L. Hirsch, J. Jackson, A. Lee, N. Halas, and J. West A whole blood immunoassay using gold nanoshells Anal. Chem. 75 2003 2377 2381 (Pubitemid 36582822)
19. C. Loo, L. Hirsch, M.-H. Lee, E. Chang, J. West, and N. Halas et al. Gold nanoshell bioconjugates for molecular imaging in living cells Opt. Lett. 30 2005 1012 1014 (Pubitemid 40749266)
20. C. Loo, A. Lowery, N. Halas, J. West, and R. Drezek Immunotargeted nanoshells for integrated cancer imaging and therapy Nano Lett. 5 2005 709 711 (Pubitemid 40609745)
21. C. Loo, A. Lin, L. Hirsch, M.-H. Lee, J. Barton, and N. Halas et al. Nanoshell-enabled photonics-based imaging and therapy of cancer Technol. Cancer Res. Treat. 3 2004 33 40 (Pubitemid 38250466)
22. P. Rubin Clinical Oncology: A Multidisiplinary Approach for Physicians and Students 8th ed. 2001 W.B. Saunders Company Philadelphia, PA
23. F.A. Fornari, J.K. Randolph, J.C. Yalowich, M.K. Ritke, and D.A. Gewirtz Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells Mol. Pharmacol. 45 1994 649 656 (Pubitemid 24139191)
24. E. Saltiel, and W. McGuire Doxorubicin (adriamycin) cardiomyopathy West. J. Med. 139 1983 332 341
25. M.S. Duxbury, H. Ito, M.J. Zinner, S.W. Ashley, and E.E. Whang EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma Oncogene 23 2004 1448 1456 (Pubitemid 38406840)
26. N.W. Gale, and G.D. Yancopoulos Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development Genes Dev. 13 1999 1055 1066 (Pubitemid 29233137)
27. C.N. Landen, A. Chavez-Reyes, C. Bucana, R. Schmandt, M.T. Deavers, and G. Lopez-Berestein et al. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery Cancer Res. 65 2005 6910 6918 (Pubitemid 41060730)
28. D.G. Duff, A. Baiker, and P.P. Edwards A new hydrosol of gold clusters. 1. Formation and particle size variation Langmuir 9 1993 2301 2309
29. Y.-K. Oh, and T.G. Park siRNA delivery systems for cancer treatment Adv. Drug Deliv. Rev. 61 2009 850 862
30. J.B. Bramsen, M.B. Laursen, A.F. Nielsen, T.B. Hansen, C. Bus, and N. Langkjaer et al. A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity Nucleic Acids Res. 37 2009 2867 2881
31. O. Mook, J. Vreijling, S.L. Wengel, J. Wengel, C. Zhou, and J. Chattopadhyaya et al. In vivo efficacy and off-target effects of locked nucleic acid (LNA) and unlocked nucleic acid (UNA) modified siRNA and small internally segmented interfering RNA (sisiRNA) in mice bearing human tumor xenografts Artif. DNA PNA XNA 1 2010 36 44
32. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 1986 6387 6392 (Pubitemid 17221789)
33. B. Hildebrandt The cellular and molecular basis of hyperthermia Crit. Rev. Oncol. Hematol. 43 2002 33 56 (Pubitemid 34722786)
34. G.M. Hahn Potential for therapy of drugs and hyperthermia Cancer Res. 39 1979 2264 2268 (Pubitemid 9185421)
35. J.B. Marmor Interactions of hyperthermia and chemotherapy in animals Cancer Res. 39 1979 2269 2276 (Pubitemid 9185422)
36. R.D. Issels Hyperthermia adds to chemotherapy Eur. J. Cancer 44 2008 2546 2554
37. B.A. Chabner, and T.G. Roberts Timeline: chemotherapy and the war on cancer Nat. Rev. Cancer 5 2005 65 72
38. R.T. Lima, L.M. Martins, J.E. Guimarães, C. Sambade, and M.H. Vasconcelos Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells Cancer Gene Ther. 11 2004 309 316 (Pubitemid 38586086)
39. X. Dong, A. Liu, C. Zer, J. Feng, Z. Zhen, and M. Yang et al. siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells BMC Cancer 9 2009 133 143
40. H. Meng, M. Liong, T. Xia, Z. Li, Z. Ji, and J.I. Zink et al. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line ACS Nano 4 2010 4539 4550
41. X.-B. Xiong, and A. Lavasanifar Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin ACS Nano 2011 5202 5213